{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:44:46Z","timestamp":1791945886387,"version":"4.3.4"},"reference-count":46,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"abstract":"<jats:p>In May 2016, the Eshelman School of Pharmacy at The University of North Carolina at Chapel Hill convened the PharmSci conference to address the topic of \u201cmethodological and ethical issues in pediatric medication safety research.\u201d A multidisciplinary group of experts representing a diverse array of perspectives, including those of the US Food and Drug Administration, children\u2019s hospitals, and academia, identified important considerations for pediatric medication safety research and opportunities to advance the field. This executive summary describes current challenges that clinicians and researchers encounter related to pediatric medication safety research and identifies innovative and ethically sound methodologies to address these challenges to improve children\u2019s health. This article addresses 5 areas: (1) pediatric drug development and drug trials; (2) conducting comparative effectiveness research in pediatric populations; (3) child and parent engagement on study teams; (4) improving communication with children and parents; and (5) assessing child-reported outcomes and adverse drug events.<\/jats:p>","DOI":"10.1542\/peds.2017-0195","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T09:10:11Z","timestamp":1501837811000},"source":"Crossref","is-referenced-by-count":17,"title":["Methodological and Ethical Issues in Pediatric Medication Safety Research"],"prefix":"10.1542","volume":"140","author":[{"given":"Delesha","family":"Carpenter","sequence":"first","affiliation":[{"name":"Division of Pharmaceutical Outcomes and Policy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapy and Experimental Therapeutics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Retsch-Bogart","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine,"},{"name":"Clinical and Translational Research Center of the North Carolina Translational and Clinical Sciences Institute, and"},{"name":"Cystic Fibrosis Therapeutics Development Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Sleath","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Outcomes and Policy,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wilfond","sequence":"additional","affiliation":[{"name":"Treuman Katz Center for Pediatric Bioethics, Seattle Children\u2019s Research Institute, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"issue":"4","key":"2021121100290492000_B1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/AOG.0000000000000743","article-title":"Lessons learned in pediatric clinical research to evaluate safe and effective use of drugs in pregnancy.","volume":"125","author":"Gonzalez","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"12","key":"2021121100290492000_B2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children.","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"2021121100290492000_B3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/cap.2006.16.159","article-title":"Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents.","volume":"16","author":"Safer","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"2021121100290492000_B4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2005.12.001","article-title":"Pharmacological research in pediatrics: from neonates to adolescents.","volume":"58","author":"Rakhmanina","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"2021121100290492000_B5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nrd1253","article-title":"Paediatric clinical trials: redressing the imbalance.","volume":"2","author":"Schreiner","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2021121100290492000_B6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1824-7288-37-12","article-title":"Framework conditions facilitating paediatric clinical research.","volume":"37","author":"Knellwolf","year":"2011","journal-title":"Ital J Pediatr"},{"issue":"16","key":"2021121100290492000_B7","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.285.16.2114","article-title":"Medication errors and adverse drug events in pediatric inpatients.","volume":"285","author":"Kaushal","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"2021121100290492000_B8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamapediatrics.2013.4208","article-title":"Drug labeling and exposure in neonates.","volume":"168","author":"Laughon","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2021121100290492000_B9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/clpt.2014.134","article-title":"Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.","volume":"96","author":"Gonzalez","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"2021121100290492000_B10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.drudis.2015.03.005","article-title":"Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.","volume":"20","author":"Kalkman","year":"2015","journal-title":"Drug Discov Today"},{"issue":"11","key":"2021121100290492000_B11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/psp4.12038","article-title":"Use of modeling and simulation in the design and conduct of pediatric clinical trials and the optimization of individualized dosing regimens.","volume":"4","author":"Stockmann","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2021121100290492000_B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0512-x","article-title":"Clinical trial simulations and pharmacometric analysis in pediatrics: application to inhaled Loxapine in children and adolescents [published online ahead of print February 15, 2017].","author":"Dong","journal-title":"Clin Pharmacokinet"},{"key":"2021121100290492000_B13","unstructured":"US Food and Drug Administration. Leveraging existing clinical data for extrapolation to pediatric uses of medical devices: draft guidance for industry and food and drug administration staff. 2015. Available at: https:\/\/www.fda.gov\/downloads\/medicaldevices\/deviceregulationandguidance\/guidancedocuments\/ucm444591.pdf. Accessed June 21, 2016"},{"key":"2021121100290492000_B14","article-title":"Leveraging adult data in pediatric product development: the role of Bayesian statistics.","volume-title":"FDA-University of Maryland CERSI Workshop","author":"Cooner"},{"issue":"5","key":"2021121100290492000_B15","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/bcp.13058","article-title":"Design and conduct of early phase drug studies in children: challenges and opportunities.","volume":"82","author":"Rieder","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"39","key":"2021121100290492000_B16","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.2174\/1381612821666150901105146","article-title":"Ethical considerations in conducting pediatric and neonatal research in clinical pharmacology.","volume":"21","author":"Roth-Cline","year":"2015","journal-title":"Curr Pharm Des"},{"issue":"3","key":"2021121100290492000_B17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cpt.165","article-title":"Microdosing studies in children: a US regulatory perspective.","volume":"98","author":"Roth-Cline","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"2021121100290492000_B18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1377\/hlthaff.2010.0594","article-title":"Special challenges in comparative effectiveness research on children\u2019s and adolescents\u2019 health.","volume":"29","author":"Simpson","year":"2010","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"2021121100290492000_B19","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-1115","article-title":"Use of electronic health record systems by office-based pediatricians.","volume":"135","author":"Lehmann","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"2021121100290492000_B20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jpeds.2012.01.039","article-title":"Comparative effectiveness research using the electronic medical record: an emerging area of investigation in pediatric primary care.","volume":"160","author":"Fiks","year":"2012","journal-title":"J Pediatr"},{"issue":"8","key":"2021121100290492000_B21","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/MLR.0b013e31829b1dbd","article-title":"Caveats for the use of operational electronic health record data in comparative effectiveness research.","volume":"51","author":"Hersh","year":"2013","journal-title":"Med Care"},{"issue":"3","key":"2021121100290492000_B22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hast.440","article-title":"The potential harms and benefits from research on medical practices.","volume":"45","author":"Wilfond","year":"2015","journal-title":"Hastings Cent Rep"},{"issue":"5","key":"2021121100290492000_B23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/1740774515597701","article-title":"The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials.","volume":"12","author":"Welch","year":"2015","journal-title":"Clin Trials"},{"issue":"9","key":"2021121100290492000_B24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamapediatrics.2015.0906","article-title":"Promoting informed decision making for comparative effectiveness randomized trials.","volume":"169","author":"Weiss","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2021121100290492000_B25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2307\/3563642","article-title":"IRB staff and members\u2019 attitudes about randomization in research on medical practices: variation in regulatory interpretations.","volume":"39","author":"Porter","year":"2017","journal-title":"IRB Ethics Hum Res."},{"issue":"4","key":"2021121100290492000_B26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/amiajnl-2014-002743","article-title":"PEDSnet: a national pediatric learning health system.","volume":"21","author":"Forrest","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"2021121100290492000_B27","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-0673","article-title":"Comparative effectiveness research through a collaborative electronic reporting consortium.","volume":"136","author":"Fiks","year":"2015","journal-title":"Pediatrics"},{"key":"2021121100290492000_B28","article-title":"A new collaborative pediatric electronic health record (EHR) network to examine off-label prescribing.","volume-title":"Proceedings from the American Academy of Pediatrics","author":"Czaja"},{"issue":"10","key":"2021121100290492000_B29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M15-0166","article-title":"Attitudes toward risk and informed consent for research on medical practices: a cross-sectional survey.","volume":"162","author":"Cho","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"2021121100290492000_B30","first-page":"1","article-title":"Waivers and alterations to consent in pragmatic clinical trials: respecting the principle of respect for persons.","volume":"38","author":"Kim","year":"2016","journal-title":"IRB"},{"issue":"4","key":"2021121100290492000_B31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/cer.15.24","article-title":"IMPACCT Kids\u2019 Care: a real-world example of stakeholder involvement in comparative effectiveness research.","volume":"4","author":"Likumahuwa-Ackman","year":"2015","journal-title":"J Comp Eff Res"},{"issue":"4","key":"2021121100290492000_B32","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1542\/peds.2012-3786J","article-title":"Collaborative chronic care networks (C3Ns) to transform chronic illness care.","volume":"131","author":"Margolis","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"2021121100290492000_B33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/amiajnl-2014-002758","article-title":"Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research.","volume":"21","author":"Daugherty","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"2021121100290492000_B34","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.acap.2013.07.004","article-title":"Pediatric collaborative networks for quality improvement and research.","volume":"13","author":"Lannon","year":"2013","journal-title":"Acad Pediatr"},{"issue":"4","key":"2021121100290492000_B35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2011-1700","article-title":"Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease.","volume":"129","author":"Crandall","year":"2012","journal-title":"Pediatrics"},{"key":"2021121100290492000_B36","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2016-103573","article-title":"\u2018Wicked problems\u2019, community engagement and the need for an implementation science for research ethics [published online ahead of print August 18, 2016].","author":"Lavery","journal-title":"J Med Ethics"},{"issue":"2","key":"2021121100290492000_B37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1525\/jer.2012.7.2.3","article-title":"Research ethics education for community-engaged research: a review and research agenda.","volume":"7","author":"Anderson","year":"2012","journal-title":"J Empir Res Hum Res Ethics"},{"issue":"3","key":"2021121100290492000_B38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pec.2003.04.003","article-title":"The role of effective communication with children and their families in fostering adherence to pediatric regimens.","volume":"55","author":"Dimatteo","year":"2004","journal-title":"Patient Educ Couns"},{"issue":"4","key":"2021121100290492000_B39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1542\/peds.2012-0913","article-title":"Communication during pediatric asthma visits and self-reported asthma medication adherence.","volume":"130","author":"Sleath","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"2021121100290492000_B40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.japh.2016.03.001","article-title":"Counseling of children and adolescents in community pharmacies: results from a 14-day observational study.","volume":"56","author":"Carpenter","year":"2016","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"2021121100290492000_B41","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ygyno.2013.12.020","article-title":"Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention.","volume":"132","author":"Brewer","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2021121100290492000_B42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4274\/jcrpe.v3i2.10","article-title":"Revised you\u2019re welcome criteria and future developments in adolescent healthcare.","volume":"3","author":"Hargreaves","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"4","key":"2021121100290492000_B43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","article-title":"Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.","volume":"16","author":"Matza","year":"2013","journal-title":"Value Health"},{"issue":"4","key":"2021121100290492000_B44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0885-3924(02)00680-2","article-title":"Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectives.","volume":"25","author":"Hockenberry","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"2021121100290492000_B45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1097-0215(1999)83:12+<46::AID-IJC9>3.0.CO;2-C","article-title":"Health-related quality of life in pediatric bone marrow transplant survivors: according to whom?","volume":"12","author":"Parsons","year":"1999","journal-title":"Int J Cancer Suppl"},{"issue":"3","key":"2021121100290492000_B46","doi-asserted-by":"crossref","first-page":"e26261","DOI":"10.1002\/pbc.26261","article-title":"Eliciting the child\u2019s voice in adverse event reporting in oncology trials: cognitive interview findings from the pediatric patient-reported outcomes version of the common terminology criteria for adverse events initiative.","volume":"64","author":"Reeve","year":"2017","journal-title":"Pediatr Blood Cancer"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-0195\/1104443\/peds_20170195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-0195\/1104443\/peds_20170195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T08:17:47Z","timestamp":1639210667000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/140\/3\/e20170195\/38285\/Methodological-and-Ethical-Issues-in-Pediatric"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9,1]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-0195","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,1]]},"article-number":"e20170195"}}